• Capsaicin Workflows for TRPV1 and KDM1A

  2026-08-28

  Capsaicin enables a two-track research strategy: functional TRPV1 ion channel activation in sensory models and reversible KDM1A/LSD1 inhibition in cancer or epigenetic assays. This practical guide connects the compound to chronic dermatitis, pain signaling, calcium imaging, and gastric cancer workflows while emphasizing controls, solvent discipline, and mechanism-focused troubleshooting.

• Sodium Picosulfate Research Workflows

  2026-08-27

  Sodium Picosulfate offers a controllable way to model intestinal fluid and electrolyte handling in constipation experiments. This guide connects phenotype-based gastrointestinal assays with carefully bounded gut–liver–brain studies, emphasizing reproducibility, controls, and troubleshooting.

• Aztreonam Workflows for Gram-Negative Research

  2026-08-27

  Aztreonam supports reproducible studies of Gram-negative bacterial inhibition, resistance phenotypes, bone marrow progenitor cell effects, and hepatic drug-metabolism changes. This practical guide connects stock preparation, susceptibility testing, cell-based assays, and microsomal workflows while keeping each application’s evidence and limitations distinct.

• Sodium dicloxacillin monohydrate: Research Workflows

  2026-08-26

  Build more interpretable MSSA experiments with a workflow that connects penicillin-binding protein inhibition, extracellular and intracellular activity, and quantitative assay control. This guide combines practical dosing design with a spectrophotometric quality-control strategy informed by a peer-reviewed reference study.

• Cefazedone PK/PD in Community-Acquired Pneumonia

  2026-08-26

  This study linked intravenous Cefazedone exposure to microbiological and clinical outcomes in adults with mild to moderate community-acquired pneumonia. Its main contribution was a clinical PK/PD assessment showing that the 2 g every 12 hours regimen produced measurable time above MIC and supported treatment of infections caused by susceptible bacteria.

• 5-Aminolevulinic acid HCl in Cell Assays

  2026-08-25

  Learn how 5-Aminolevulinic acid HCl, SKU B2070, can improve experimental control in heme-pathway, viability, proliferation, and photodynamic workflows. This scenario-based guide covers assay compatibility, solution handling, data interpretation, and practical vendor selection using documented product specifications and recent haem-biology evidence.

• Temafloxacin in Intracellular Antibacterial Assays

  2026-08-25

  Temafloxacin is a fluoroquinolone broad-spectrum antibacterial agent whose value extends beyond conventional MIC testing. This guide explains how to connect target-level activity, extracellular susceptibility, combination effects, and macrophage-based intracellular killing using evidence from Mycobacterium avium complex research.

• Cefodizime Workflows for Resistance Research

  2026-08-24

  Build reproducible Cefodizime assays that connect PBP-targeted bactericidal activity with isolate-level resistance surveillance. The workflow combines MIC testing, time-kill analysis, exposure controls, and hospital-use context without confusing research observations with clinical treatment guidance.

• Faropenem Sodium: Penem Antibiotic Workflows

  2026-08-23

  Faropenem sodium supports integrated bacterial inhibition, anaerobe, resistance, and renal transporter workflows rather than a single endpoint assay. Its penem-class activity and documented NPT1 substrate recognition create a practical bridge between antimicrobial pharmacology and epithelial transport research.

• Dye Models for Small Biopsy Visibility in Pathology

  2026-08-22

  The reference study evaluates five dyes as pre-processing markers for small tissue biopsies and shows that merbromin, hematoxylin, and Alcian blue improve visual recognition during tissue preparation. Its practical contribution is the comparison of visibility with diagnostic interference, leading the authors to favor hematoxylin as the most suitable routine marker.

• Phosbind Acrylamide for Phosphorylation Analysis

  2026-08-21

  Phosbind Acrylamide is a phosphate-binding reagent for antibody-free protein phosphorylation analysis by SDS-PAGE. The F4002 formulation uses MnCl2-associated phosphate interaction to produce phosphorylation-dependent mobility shifts, with product guidance focused on proteins from 30–130 kDa.

• Ethanol, mTOR–EZH2, and Hippocampal Spine Remodeling

  2026-08-20

  This study uses lineage tracing to show that adolescent ethanol exposure persistently alters Nestin-lineage neural stem cell orientation, neurogenesis, newborn neuron positioning, and dendritic spine remodeling in the adult mouse dentate gyrus. Its rescue experiments implicate the mTOR–EZH2 pathway and voluntary running, providing a mechanistic framework for studying alcohol-related hippocampal plasticity rather than relying only on endpoint proliferation measurements.

• U-73122: Practical PLC Signaling Workflows

  2026-08-20

  U-73122 is a mechanism-focused phospholipase C inhibitor for connecting PIP2 turnover with calcium flux, chemotaxis, and cancer-cell invasion. This guide translates PLC-β2 inhibition into reproducible workflows, assay controls, and troubleshooting decisions.

• Irisin Protects Renal Mitochondria After I/R

  2026-08-19

  Cui and colleagues show that irisin protects renal tubular epithelial cells from ischemia–reperfusion injury by preserving mitochondrial integrity and function. By combining patient associations, a mouse intervention model, ex vivo tubular imaging, and mitochondrial pathway analyses, the study connects irisin with PINK1/Parkin-related mitochondrial quality control in acute kidney injury.

• Temafloxacin Against Gram-Negative Bacteria: Study Analysis

  2026-08-19

  This analysis examines Hardy’s comparative overview of Temafloxacin, ciprofloxacin, and ofloxacin across respiratory, sexually transmitted, enteric, and opportunistic Gram-negative pathogens. The study’s central contribution is its species-resolved interpretation of in vitro potency, showing strong activity against many respiratory and enteric organisms while identifying comparatively weaker activity against Pseudomonas aeruginosa.

443 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page